Success Metrics

Clinical Success Rate
88.2%

Based on 15 completed trials

Completion Rate
88%(15/17)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
2(11%)

Phase Distribution

Ph not_applicable
7
39%
Ph phase_1
1
6%
Ph phase_2
6
33%
Ph phase_3
4
22%

Phase Distribution

1

Early Stage

6

Mid Stage

4

Late Stage

Phase Distribution18 total trials
Phase 1Safety & dosage
1(5.6%)
Phase 2Efficacy & side effects
6(33.3%)
Phase 3Large-scale testing
4(22.2%)
N/ANon-phased studies
7(38.9%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

83.3%

15 of 18 finished

Non-Completion Rate

16.7%

3 ended early

Currently Active

0

trials recruiting

Total Trials

18

all time

Status Distribution
Completed(15)
Terminated(3)

Detailed Status

Completed15
Terminated2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
18
Active
0
Success Rate
88.2%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (5.6%)
Phase 26 (33.3%)
Phase 34 (22.2%)
N/A7 (38.9%)

Trials by Status

withdrawn16%
terminated211%
completed1583%

Recent Activity

Clinical Trials (18)

Showing 18 of 18 trials
NCT00000810Phase 1

Randomized, Phase I/II, Dose-Ranging, Open-Label Trial of the Anti-HIV Activity of Delavirdine Mesylate (DLV; U-90,152S)

Completed
NCT00000803Phase 2

A Phase II Double-Blind Study of Delavirdine Mesylate ( U-90152 ) in Combination With Zidovudine ( AZT ) and/or Didanosine ( ddI ) Versus AZT and ddI Combination Therapy

Completed
NCT00000891Phase 2

Immunologic and Virologic Consequences of Long-Term Highly Active Antiretroviral Therapy (HAART) in Subjects With Moderately Advanced HIV-1 Disease: A Follow-Up Study to ACTG 315

Completed
NCT00000892Not Applicable

A Study of Several Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Used Indinavir

Completed
NCT00001094Phase 2

A Comparison of Nelfinavir Plus Saquinavir Plus Delavirdine or 3TC/ZDV Versus Nelfinavir Plus 3TC/ZDV in HIV-Infected Patients

Withdrawn
NCT00000882Phase 2

Virologic and Immunologic Activity of Continued Lamivudine (3TC) vs Delavirdine (DLV) in Combination With Indinavir (IDV) and Zidovudine (ZDV) or Stavudine (d4T) in 3TC-Experienced Subjects

Completed
NCT00002420Phase 2

The Safety and Effectiveness of Didanosine Plus Stavudine Plus Delavirdine Mesylate Plus MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors

Terminated
NCT00002178Phase 3

A Phase IIIB Open-Label, Comparative Study to Evaluate Saquinavir Soft Gel Capsule (SGC) Treatment in Combination With Other Antiretrovirals in HIV-1 Infected Antiretroviral-Naive Patients

Completed
NCT00002401Not Applicable

A Study of Delavirdine Used Together With Other Anti-HIV Drugs in HIV-Infected Patients

Completed
NCT00002123Phase 3

A Double-Blind, Randomized, Comparative Study of Delavirdine Mesylate (U-90152S) in Combination With Didanosine (ddI) Versus ddI Alone in HIV-1 Infected Individuals With CD4 Counts of <= 300/mm3

Completed
NCT00002400Not Applicable

A Study of Two Anti-HIV Drug Combinations in HIV-Infected Patients

Completed
NCT00002312Not Applicable

The Safety and Effectiveness of U-90152 in HIV-1 Infected Patients Who Take Zidovudine

Completed
NCT00002236Not Applicable

A Study to Find the Best Dosing Schedule for Delavirdine, Zidovudine, and Indinavir in HIV-Positive Patients

Completed
NCT00002211Not Applicable

Safety and Effectiveness of Giving Combinations of Three or Four Anti-HIV Drugs to HIV-Infected Patients

Completed
NCT00002124Phase 3

A Double-Blind, Randomized, Dose Response Study of Three Doses of Delavirdine Mesylate (U-90152S) in Combination With Zidovudine (ZDV) Versus ZDV Alone in HIV-1 Infected Individuals With CD4 Counts of 200-500mm3

Completed
NCT00002378Phase 3

A Comparison of Three Anti-HIV Drug Combinations Containing Saquinavir Soft Gelatin Capsules Used in HIV-1 Infected Patients

Completed
NCT00002210Phase 2

A Study of Delavirdine Mesylate in Combination With Other Anti-HIV Drugs in HIV-Infected Children and Babies

Completed
NCT00006326Not Applicable

Safety and Effectiveness of 3 Anti-HIV Treatments in Patients Who Have Failed Previous Treatments Containing Nelfinavir

Terminated

All 18 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
18